tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Seamus Fernandez, 192 are a BUY (82.76%), 40 are a HOLD (17.24%).
Analyst Seamus Fernandez, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 48.2% that have a potential upside of 49.05% achieved within 342 days.
Seamus Fernandez’s has documented 450 price targets and ratings displayed on 38 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on LLY, Eli Lilly and Company at 17-Sep-2026.
Analyst best performing recommendations are on ADGI (ADAGIO THERAPEUTICS).
The best stock recommendation documented was for VIE (VIELA BIO) at 1/7/2020. The price target of $45 was fulfilled within 9 days with a profit of $17.12 (61.41%) receiving and performance score of 68.23.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 21-Dec-2016
$193
$-0.02 (-0.01%)
6 years 5 months 8 days ago
(21-Apr-2020)
2/8 (25%)
$8.96 (4.87%)
125
Hold Since 08-May-2019
$203
$9.98 (5.17%)
$178
6 years 7 months 19 days ago
(10-Feb-2020)
5/19 (26.32%)
$4.87 (2.46%)
74
Buy Since 03-Aug-2017
$198
$4.98 (2.58%)
$188
6 years 8 months 7 days ago
(22-Jan-2020)
3/12 (25%)
$7.8 (4.10%)
176
$203
$9.98 (5.17%)
$189
6 years 10 months 10 days ago
(19-Nov-2019)
1/2 (50%)
$19.19 (10.44%)
96
Buy Since 03-Aug-2015
$200
6 years 10 months 10 days ago
(19-Nov-2019)
2/12 (16.67%)
$73.92 (58.63%)
290
Which stock is Seamus Fernandez most bullish on?
Which stock is Seamus Fernandez most reserved on?
What Year was the first public recommendation made by Seamus Fernandez?
